ALT Bioscience
Advancing diagnostic and biomedical technologies to enhance oral-systemic health and combat neurodegenerative diseases.
Advancing diagnostic and biomedical technologies to enhance oral-systemic health and combat neurodegenerative diseases.
ALT Bioscience is a biotechnology and pharmaceutical company that was founded in 1997 with a mission to advance diagnostic and biomedical technologies. Headquartered in Lexington, Kentucky, the company is dedicated to enhancing oral-systemic health and combatting neurodegenerative diseases. Their slogan "Advancing diagnostic and biomedical technologies to enhance oral-systemic health and combat neurodegenerative diseases" encapsulates their core focus. In June 2015, ALT Bioscience secured a significant $6.38M in their Venture Round investment, signifying a strong interest from investors in their innovative approach. As the company continues to make strides in the biotechnology and pharmaceutical industries, their dedication to advancing healthcare technologies positions them as an intriguing contender for further investment and market impact.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $6.38M | - | 26 Jun 2015 | |
| Venture Round | $920.19K | - | 16 Sep 2010 | |
| Venture Round | $853.50K | - | 13 Nov 2009 |
No recent news or press coverage available for ALT Bioscience.
We care about your data, and we'd love to use cookies make your experience better.
